BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31243669)

  • 21. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
    He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
    Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CircKIAA0907 Retards Cell Growth, Cell Cycle, and Autophagy of Gastric Cancer In Vitro and Inhibits Tumorigenesis In Vivo via the miR-452-5p/KAT6B Axis.
    Zhu L; Wang C; Lin S; Zong L
    Med Sci Monit; 2020 Jul; 26():e924160. PubMed ID: 32722658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of microRNA-193-3p inhibits tumor proliferation migration and chemoresistance in human gastric cancer by regulating PTEN gene.
    Jian B; Li Z; Xiao D; He G; Bai L; Yang Q
    Tumour Biol; 2016 Jul; 37(7):8941-9. PubMed ID: 26753960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of miR-584-5p inhibits proliferation and induces apoptosis by targeting WW domain-containing E3 ubiquitin protein ligase 1 in gastric cancer.
    Li Q; Li Z; Wei S; Wang W; Chen Z; Zhang L; Chen L; Li B; Sun G; Xu J; Li Q; Wang L; Xu Z; Xia Y; Zhang D; Xu H; Xu Z
    J Exp Clin Cancer Res; 2017 Apr; 36(1):59. PubMed ID: 28431583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-324-3p promotes gastric cancer development by activating Smad4-mediated Wnt/beta-catenin signaling pathway.
    Sun GL; Li Z; Wang WZ; Chen Z; Zhang L; Li Q; Wei S; Li BW; Xu JH; Chen L; He ZY; Ying K; Zhang X; Xu H; Zhang DC; Xu ZK
    J Gastroenterol; 2018 Jun; 53(6):725-739. PubMed ID: 29103082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dihydroartemisinin induces apoptosis in human gastric cancer cell line BGC-823 through activation of JNK1/2 and p38 MAPK signaling pathways.
    Zhang S; Shi L; Ma H; Li H; Li Y; Lu Y; Wang Q; Li W
    J Recept Signal Transduct Res; 2017 Apr; 37(2):174-180. PubMed ID: 27401020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1.
    Fang Z; Yin S; Sun R; Zhang S; Fu M; Wu Y; Zhang T; Khaliq J; Li Y
    Mol Cancer; 2017 Aug; 16(1):139. PubMed ID: 28818100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long noncoding RNA NEAT1 promotes the growth of gastric cancer cells by regulating miR-497-5p/PIK3R1 axis.
    Xia TF; Chen J; Wu K; Zhang J; Yan Q
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6914-6926. PubMed ID: 31486491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diallyl trisulfide suppresses tumor growth through the attenuation of Nrf2/Akt and activation of p38/JNK and potentiates cisplatin efficacy in gastric cancer treatment.
    Jiang XY; Zhu XS; Xu HY; Zhao ZX; Li SY; Li SZ; Cai JH; Cao JM
    Acta Pharmacol Sin; 2017 Jul; 38(7):1048-1058. PubMed ID: 28344324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-5590-3p inhibited tumor growth in gastric cancer by targeting DDX5/AKT/m-TOR pathway.
    Wu N; Han Y; Liu H; Jiang M; Chu Y; Cao J; Lin J; Liu Y; Xu B; Xie X
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1491-1497. PubMed ID: 30029874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-129-5p inhibits liver cancer growth by targeting calcium calmodulin-dependent protein kinase IV (CAMK4).
    Li Z; Lu J; Zeng G; Pang J; Zheng X; Feng J; Zhang J
    Cell Death Dis; 2019 Oct; 10(11):789. PubMed ID: 31624237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation and tumor-promoting role of SPHK1 were attenuated by miR-330-3p in gastric cancer.
    Wang Z; Qu H; Gong W; Liu A
    IUBMB Life; 2018 Nov; 70(11):1164-1176. PubMed ID: 30281914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis.
    Zhou Y; Huang T; Zhang J; Wong CC; Zhang B; Dong Y; Wu F; Tong JHM; Wu WKK; Cheng ASL; Yu J; Kang W; To KF
    Oncogene; 2017 Nov; 36(47):6518-6530. PubMed ID: 28759040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. microRNA-29c inhibits cell proliferation by targeting NASP in human gastric cancer.
    Yu B; Chen X; Li J; Gu Q; Zhu Z; Li C; Su L; Liu B
    BMC Cancer; 2017 Feb; 17(1):109. PubMed ID: 28173777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-34a, as a suppressor, enhance the susceptibility of gastric cancer cell to luteolin by directly targeting HK1.
    Zhou Y; Ding BZ; Lin YP; Wang HB
    Gene; 2018 Feb; 644():56-65. PubMed ID: 29054762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4.
    Zhao G; Wang B; Liu Y; Zhang JG; Deng SC; Qin Q; Tian K; Li X; Zhu S; Niu Y; Gong Q; Wang CY
    Mol Cancer Ther; 2013 Nov; 12(11):2569-80. PubMed ID: 24013097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4.
    Xu X; Gao F; Wang J; Tao L; Ye J; Ding L; Ji W; Chen X
    Cancer Biol Ther; 2018 May; 19(5):427-435. PubMed ID: 29509059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1.
    Shang Y; Zhang Z; Liu Z; Feng B; Ren G; Li K; Zhou L; Sun Y; Li M; Zhou J; An Y; Wu K; Nie Y; Fan D
    Oncogene; 2014 Jun; 33(25):3267-76. PubMed ID: 23893241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sanguinarine inhibits epithelial-mesenchymal transition via targeting HIF-1α/TGF-β feed-forward loop in hepatocellular carcinoma.
    Su Q; Fan M; Wang J; Ullah A; Ghauri MA; Dai B; Zhan Y; Zhang D; Zhang Y
    Cell Death Dis; 2019 Dec; 10(12):939. PubMed ID: 31819036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine.
    Yang J; Fang Z; Wu J; Yin X; Fang Y; Zhao F; Zhu S; Li Y
    Tumour Biol; 2016 Oct; 37(10):13871-13883. PubMed ID: 27485114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.